# US 2006/0068409 A1 · Use of restriction enzymes and other chemical methods to decrease non-specific binding in dual bead assays and related bio-discs, methods, and system apparatus for detecting medical targets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068409 A1
- Document ID: US20060068409A1
- Status: Published application
- Kind: A1
- Application number: 11/069,760
- Filed: 2005-02-28
- Published: 2006-03-30
- Earliest claimed: 2000-11-27
- Inventors: Brigitte Phan; Jorma Virtanen; Amethyst Lam; KaYuen Yeung; James Coombs
- Web page: https://patentgrep.com/patent/US20060068409A1

## CPC

- B01L 3/545: {for laboratory containers}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- B03C 1/01: by addition of magnetic adjuvants
- B03C 1/288: {disposed at the outer circumference of a recipient}
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- F16K 99/0001: {Microvalves (microdevices B81B1/00; manufacture or treatment of devices or systems in or on a substrate B81C1/00; microfluidic structures B01L3/5027; micropumps F04B19/006)}
- F16K 99/0023: {with ball-shaped valve members}
- F16K 99/0034: {Operating means specially adapted for microvalves}
- G01N 27/745: {for detecting magnetic beads used in biochemical assays (concerning the assays G01N33/54326; sensors therefor G01R33/1269; automatic analysers therefor G01N35/0098)}
- G01N 33/54313: {the carrier being characterised by its particulate form}
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- B01L 2300/021: Identification, e.g. bar codes
- B01L 2300/0636: Integrated biosensor, microarrays
- B01L 2300/0806: Standardised forms, e.g. compact disc [CD] format
- B01L 2400/0409: centrifugal forces
- B01L 2400/0622: distribution valves, valves having multiple inlets and/or outlets, e.g. metering valves, multi-way valves
- B01L 2400/0633: with moving parts
- B01L 2400/0683: mechanically breaking a wall or membrane within a channel or chamber
- B03C 2201/18: Magnetic separation whereby the particles are suspended in a liquid
- B03C 2201/26: for use in medical or biological applications
- F16K 2099/008: {Multi-layer fabrications}
- F16K 2099/0084: {Chemistry or biology, e.g. "lab-on-a-chip" technology}
- G01N 35/00069: {whereby the sample substrate is of the bio-disk type, i.e. having the format of an optical disk}
- G01N 35/0098: {involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation (magnetic particles used in immunoassays G01N33/54326; magnetic separation in general B03C)}
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B03C: MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS (separating isotopes B01D59/00; combinations of magnetic or electrostatic separation with separation of solids by other means B03B, B07B)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- F16K: VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING {(devices for emptying and evacuating the excess liquid in valves or conduits F16L55/07)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods for decreasing non-specific bindings of beads in dual bead assays and related optical bio-discs and disc drive systems. Methods include identifying whether a target agent is present in a biological sample and mixing capture beads each having at least one transport probe affixed thereto, reporter beads each having at least one signal probe affixed thereto, and a biological sample. Mixing is performed under binding conditions to permit formation of a dual bead complex if the target agent is present in the sample. The reporter bead and capture bead each are bound to the target agent. Denaturing the target agent and keeping it in the denatured form by use of a specialized hybridization buffer is also provided. A denaturing agent is guanidine isothiocynate. Methods further include isolating the dual bead complex from the mixture to obtain an isolate, exposing the isolate to a capture field on a disc, and detecting the presence of the dual bead complex in the disc to indicate that the target agent is present in the sample. The methods may further include selectively breaking up non-specific binding between capture beads and reporter beads employing a digestion agent. Also employed is a method for selectively breaking up non-specific binding between capture beads and reporter beads using a wash buffer containing a chemical agent. The methods are applied to detecting medical targets.

## Claims

### Claim 1

An optical bio-disc, comprising:
a substrate having encoded information associated therewith, said encoded information being readable by a disc drive assembly to control rotation of the disc;
a target zone associated with said substrate, said target zone disposed at a predetermined location relative to said substrate;
an active layer associated with said target zone;
a plurality of capture agents attached to said active layer so that when said substrate is rotated, said capture agents remain attached to said active layer to thereby maintain a number of said capture agents within said target zone; and
a dual bead complex attached to said capture agents, wherein said dual bead complex has been pre-washed in a buffer containing a dissociation agent.

### Claim 2 (depends on 1)

The optical bio-disc according to claim 1, wherein said capture agent is selected from the group consisting of a single stranded oligonucleotide sequence, a double stranded oligonucleotide sequence, an antibody, an antigen, biotin, and streptavidin.

### Claim 3 (depends on 1)

The optical bio-disc according to claim 1, wherein said active layer is disposed between said substrate and a cap.

### Claim 4 (depends on 1)

The optical bio-disc according to claim 1, wherein said active layer is selected from the group consisting of nitrocellulose, polystyrene, polycarbonate, gold, activated glass, modified glass, and modified polystyrene.

### Claim 5 (depends on 1)

The optical bio-disc according to claim 1, wherein said dissociation agent is an enzyme.

### Claim 6 (depends on 5)

The optical bio-disc according to claim 5, wherein said enzyme is a DNase.

### Claim 7 (depends on 1)

The optical bio-disc according to claim 1, wherein said dissociation is a chaotropic agent.

### Claim 8 (depends on 7)

The optical bio-disc according to claim 7, wherein said chaotropic agent is urea.

### Claim 9 (depends on 7)

The optical bio-disc according to claim 7, wherein said chaotropic agent is guanidine isothiocyanate.

### Claim 10

An optical bio-disc assay system, comprising:
a substrate having encoded information associated therewith, said encoded information being readable by a disc drive assembly to control rotation of the disc;
a target zone associated with said substrate, said target zone disposed at a predetermined location relative to said substrate;
an active layer associated with said target zone;
a plurality of capture agents attached to said active layer so that when said substrate is rotated, said capture agents remain attached to said active layer to thereby maintain a number of said capture agents within said target zone; and
a dual bead complex which interacts with said capture agents, wherein said dual bead complex has been pre-washed in a buffer containing a dissociation agent.

### Claim 11 (depends on 10)

The optical bio-disc bio-disc according to claim 10, wherein said capture agent is selected from the group consisting of a single stranded oligonucleotide sequence, a double stranded oligonucleotide sequence, an antibody, an antigen, biotin, or and streptavidin.

### Claim 12 (depends on 10)

The optical bio-disc according to claim 10, wherein said active layer is disposed between said substrate and a cap.

### Claim 13 (depends on 10)

The optical bio-disc according to claim 10, wherein said active layer is selected from the group consisting of nitrocellulose, polystyrene, polycarbonate, gold, activated glass, modified glass, and modified polystyrene.

### Claim 14 (depends on 10)

The optical bio-disc according to claim 10, wherein said dissociation agent is an enzyme.

### Claim 15 (depends on 14)

The optical bio-disc according to claim 14, wherein said enzyme is a DNase.

### Claim 16 (depends on 10)

The optical bio-disc according to claim 10, wherein said dissociation is a chaotropic agent.

### Claim 17 (depends on 16)

The optical bio-disc according to claim 16, wherein said chaotropic agent is urea.

### Claim 18 (depends on 16)

The optical bio-disc according to claim 16, wherein said chaotropic agent is guanidine isothiocyanate.
